| 发明名称 |
Renal cell carcinoma treatment |
| 摘要 |
Methods for treating treatment-naive as well as treatment-experienced patients having RCC to achieve at least a partial tumor response involving administering a therapeutically effective amount of pegylated interferon-alpha, e.g., pegylated interferon alpha-2b as monotherapy or in association with a therapeutically effective amount of IL-2 are disclosed.
|
| 申请公布号 |
US6605273(B2) |
申请公布日期 |
2003.08.12 |
| 申请号 |
US20010901522 |
申请日期 |
2001.07.09 |
| 申请人 |
SCHERING CORPORATION |
发明人 |
RYBACK MARY ELLEN;ROSE ESTHER HELEN |
| 分类号 |
A61K38/21;A61K47/48;(IPC1-7):A61K38/21;A61K45/00;A61K38/00;C07K17/00;A23J1/00 |
主分类号 |
A61K38/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
